Top-News
Pharmazeutika Schweden

Biogaia Aktie

Aktie
WKN:  A3DL7T ISIN:  SE0017769995 US-Symbol:  BGLAF
9,48 €
+0,015 €
+0,16%
13.12.24
Handeln Depot/Watchlist
Aktienanzahl *
97,28 Mio.
Marktkapitalisierung *
899,35 Mio. €
Streubesitz
48,18%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 29.01.2024

Biogaia News

06.05.22 - PLX
BioGaia Q1 Net Income SEK 76.3 Million
(PLX AI) – BioGaia Q1 sales SEK 283.9 million vs. estimate SEK 253 million. • Q1 EBIT SEK 95.3 million vs. estimate SEK 58 million
25.04.22 - PLX
BioGaia Q1 Sales SEK 284 Million vs. Estimate SEK 240 Million
(PLX AI) – BioGaia Q1 EBIT SEK 95 million vs. estimate SEK 52 million.
04.02.22 - PLX
BioGaia Q4 Net Income SEK 38.3 Million vs. Estimate SEK 43 Million
(PLX AI) – BioGaia Q4 sales SEK 206.2 million vs. estimate SEK 200 million. • Q4 EBIT SEK 53.1 million vs. estimate SEK 57 million
21.10.21 - PLX
BioGaia Q3 Net Income SEK 52.8 Million vs. Estimate SEK 35 Million
(PLX AI) – BioGaia Q3 sales SEK 173.8 million vs. estimate SEK 157 million. • Q3 EBIT SEK 67.2 million vs. estimate SEK 46 million
13.10.21 - PLX
BioGaia Q3 Sales SEK 174 Million vs. Estimate SEK 157 Million
(PLX AI) – BioGaia Q3 EBIT SEK 67 million vs. estimate SEK 46 million.
12.08.21 - PLX
BioGaia Q2 Net Income SEK 54.7 Million vs. Estimate SEK 58 Million
(PLX AI) – BioGaia Q2 sales SEK 203.1 million vs. estimate SEK 219 million. • Q2 EBIT SEK 69.2 million vs. estimate SEK 76 million
08.02.18 - PR Newswire
BioGaia AB - Year-end report 2017
BioGaia AB - Year-end report 2017 PR Newswire
29.05.12 - Aktiencheck
BioGaia-Aktie: günstige Einstiegsmöglichkeit scheint gekommen zu sein - Global Biotech Investing
Nach Ansicht der Experten von "Global Biotech Investing" können Anleger sich erste Aktien von BioGaia ins Depot legen. Das Unternehmen sehe sich nach eigenen Angaben als ...
15.02.12 - GlobeNewswire
BioGaia extends collaboration with Nestlé
BioGaia extends collaboration with Nestlé Since 2008, BioGaia and Nestlé have collaborated in the field of infant nutrition products. The parties have now signed agreements to ...
10.02.12 - GlobeNewswire
BioGaia AB : Year-end report 2011
BioGaia AB : Year-end report 2011 BioGaia AB Year-end report 2011 (Figures in brackets refer to the same period of last year) 2011 -     Net sales reached SEK 315.0 million ...
10.11.11 - Hugin
Results from two studies: BioGaia Gastrus in Helicobacter pylori infected patients
Results from two studies: BioGaia Gastrus in Helicobacter pylori infected patients BioGaia's new probiotic tablet BioGaia Gastrus has been tested in two independent clinical trials ...
25.10.11 - Hugin
BioGaia AB : Interim report 1 January - 30 September 2011
BioGaia AB Interim report 1 January - 30 September 2011 (Figures in brackets refer to the same period of last year) Interim period, 1 January - 30 September 2011 -    Net sales ...
17.10.11 - Hugin
BioGaia signs new exclusive distribution agreement with Victus
BioGaia signs new exclusive distribution agreement with Victus The agreement refers to sales of BioGaia's Probiotic drops and tablets in Venezuela and Puerto Rico under the ...
21.09.11 - Hugin
BioGaia signs agreement with the largest pharmaceutical company in the Philippines for its probiotic chewable tablets
BioGaia signs agreement with the largest pharmaceutical company in the Philippines for its probiotic chewable tablets Today BioGaia signed a distribution agreement with United ...
18.08.11 - Hugin
BioGaia signs exclusive agreement with Fleet Laboratories in U.S.
BioGaia has signed an agreement with Fleet Laboratories for the exclusive rights to sell BioGaia's Probiotic tablets with strawberry flavour in the U.S. and its territories (excluding ...
17.08.11 - Hugin
BioGaia AB Interim report 1 January - 30 June 2011
BioGaia AB Interim report 1 January - 30 June 2011 (Figures in brackets refer to the same period of last year) Interim period, 1 January - 30 June 2011 -    Net sales reached SEK ...
04.08.11 - Hugin
BioGaia signs agreement with Moroccan pharmaceutical company Galenica SA for Morocco
BioGaia signs agreement with Moroccan pharmaceutical company Galenica SA for Morocco The agreement with Galenica gives the company exclusive rights to distribute BioGaia's ...
14.01.11 - Hugin
BioGaia's fifty-percent owned company TwoPac invests in a new facility in Eslöv
TwoPac, which is 50 % owned by BioGaia and 50 % by TwoPac's management, produces straws and oil drops containing probiotics as well as Life Top Cap, a bottle cap which ...
11.01.11 - Hugin
BioGaia signs agreement for its new Oral Rehydration Solution product for Greece
BioGaia has signed an agreement with Cube Pharmaceuticals giving the company exclusive rights to distribute BioGaia's new Oral Rehydration Solution (ORS) product with ...
08.12.10 - Hugin
New study published: Lactobacillus reuteri Protectis reduced regurgitation and improved stomach emptying in infants
The study showed that infants supplemented with L. reuteri Protectis significantly reduced the frequency of regurgitation by 80 %. Gastric emptying was also significantly accelerated ...

Newssuche

Videos

newspaper
13.12.24
TRADING Insights Webinar vom 12.12.24
Themen: Aktienmarkt-​Entwicklung, Soft-​Commodities, wie Baumwolle, Kakao, Orangensaft, aber auch die ... Mehr »